Cell-free protein synthesis of influenza virus hemagglutinin HA2-integrated virosomes for siRNA delivery.

Cell-free protein synthesis Influenza virus hemagglutinin HA2 Lipid nanoparticles Virosome pH dependent siRNA delivery

Journal

International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127

Informations de publication

Date de publication:
25 Jul 2022
Historique:
received: 21 02 2022
revised: 13 05 2022
accepted: 01 06 2022
pubmed: 12 6 2022
medline: 14 7 2022
entrez: 11 6 2022
Statut: ppublish

Résumé

It is well known that the difficulty of siRNA therapeutic application is the lack of safe and effective delivery vector. Virosome is a nano vesicle composed of lipid membrane and membrane protein. It retains fusion protein without virus genetic material, and therefore has the reduced immunogenicity compared with viral vector. Virosomes have the potential to deliver protein and nucleic acid drugs, but the traditional preparation method of virosomes is quite limited. In this study, we firstly proposed to synthesize influenza virus hemagglutinin HA2 virosomes by cell-free protein synthesis. In this study, liposomes provided the hydrophobic lipid bilayer environment for the formation of HA2 protein multimer, which inhibited the aggregation of hydrophobic HA2 and improved HA2 protein expression. Chitosan as a rigid core adsorbed siRNA and improved the encapsulation efficiency of siRNA. In conclusion, the cell-free protein synthesis was used to prepare HA2 virosomes, which paves the way for constructing a novel nano vector with high delivery efficiency and biosafety for the delivery of siRNA.

Identifiants

pubmed: 35690307
pii: S0378-5173(22)00445-8
doi: 10.1016/j.ijpharm.2022.121890
pii:
doi:

Substances chimiques

Hemagglutinin Glycoproteins, Influenza Virus 0
Hemagglutinins 0
Liposomes 0
RNA, Small Interfering 0
Virosomes 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

121890

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

Yichen Wang (Y)

School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.

Bo Jin (B)

The First Hospital, China Medical University, Department of Medical Oncology, Shenyang 110001, China.

Bao Li (B)

School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.

Yucen Luo (Y)

School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.

Mengrui Ma (M)

School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.

Yongfeng Chen (Y)

School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.

Hui Liu (H)

School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.

Huichao Xie (H)

School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.

Tianzhi Yang (T)

Department of Basic Pharmaceutical Sciences, School of Pharmacy, Husson University, Bangor, ME 04401, USA.

Xiaoyun Zhao (X)

School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang 110016, China.

Pingtian Ding (P)

School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China; College of Pharmacy, Shenzhen Technology University, Shenzhen 518118, China. Electronic address: dingpingtian@syphu.edu.cn.

Articles similaires

1.00
Nanoparticles Molecular Dynamics Simulation Hydrogen-Ion Concentration Lipids SARS-CoV-2
Streptococcus mutans Tolonium Chloride Photosensitizing Agents Liposomes Anti-Bacterial Agents

Cationized extracellular vesicles for gene delivery.

Natalia L Klyachko, Matthew J Haney, Anton V Lopukhov et al.
1.00
Extracellular Vesicles Humans Gene Transfer Techniques Cations Cell Line, Tumor
Animals Chondrocytes Nanoparticles Humans RNA, Small Interfering

Classifications MeSH